CD274 and Sepsis: Given the similarities in immunological backgrounds of both ARDS and sepsis patients, there may be a potential benefit of anti-PD-L1 antibody therapy for ARDS patients as there is considerable overlap in mRNAs and miRNAs that are differentially expressed in diseased and healthy individuals (35).